"
Circulating IgG antibody against FOXP3 may be a potential biomarker for lung cancer"
written by Weili Wang, Leiguang Ye, Xiaomei Li, Songlei Guan, Shilong Sun, Meng Wang, Xueqing Guan, Kuang-Hui Lee, Jun Wei, Baogang Liu,
published by
Advances in Lung Cancer,
Vol.2 No.4, 2013
has been cited by the following article(s):
|
[1]
|
Circulating levels of FoxP3, M2 (sCD163) and IGF-1 as potential biomarkers associated with Laryngeal Squamous Cell Carcinoma in Tunisian patients
Journal of Immunoassay and Immunochemistry,
2024
DOI:10.1080/15321819.2023.2275802
|
|
|
|
|
[2]
|
Cancer serum biomarkers based on aberrant post-translational modifications of glycoproteins: Clinical value and discovery strategies
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
2015
DOI:10.1016/j.bbcan.2015.07.002
|
|
|
|